Sandra Coenen

Sandra Coenen is a Researcher in the Department of Gastroenterology & Hepatology at Erasmus MC, Erasmus University Rotterdam. Her work focuses on clinical hepatology with emphasis on rare liver disorders and gastrointestinal pathologies, particularly erythropoietic protoporphyria and congenital portosystemic shunts.

Her research spans Hepatology, Gastroenterology, and Liver Disease with specific expertise in Porphyria, Hepatic Encephalopathy, Liver Transplantation, and Portosystemic Shunt pathologies. She investigates liver involvement mechanisms in metabolic disorders, acute liver failure triggers from dietary supplements, and management protocols for vascular liver anomalies through clinical cohort studies and interventional trials.

Analysis of her 2019-2022 publications reveals consistent focus on observational hepatology research with high clinical impact. Her work on erythropoietic protoporphyria (2022) and Abernethy Malformation (2020) established critical prevalence data and management frameworks, while the PEARL trial (2020) directly influenced hepatic encephalopathy prevention protocols. These studies demonstrate methodological rigor in cohort design and randomized controlled trials, contributing to two clinical guideline sources and international hepatology discourse.